Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RDY: Nobody has explained how you profit off a stock that stopped trading because the company was dissolved. Everyone seems to admit that it will never trade again.
KEYO will never trade again.
There's outstanding Factual Information with links and NOT hearsay rubbish opinions!
Why anyone would think a "Tracking" Stock could go public w/out the Parent company being PUBCO, just clearly can NOT comprehend the FACTS/TRUTH of how it's done. The links for reverse merger, tracking stock IPO (not normal IPO) have been posted over and over and over.
Time will tell and THIS YEAR!
Rock On NANT-Works / KEYO Shell RTM and NantHealth Tracking Stock IPO 2016!
lesn: Dell, a private company is using VMWare as a publicly traded tracking stock. Nantworks does not have to public to be a parent in any go-public transaction.
Your first quote would be the opposite of a tracking stock and I don't see Soon-Shiong going for debt financing.
RDY: Check this out:
http://www.referenceforbusiness.com/encyclopedia/Gov-Inc/Holding-Companies.html#ixzz4356uCHww
Another advantage is that shares of stock in the subsidiary company are held as assets on the books of the parent company and can be used as collateral for additional debt financing. In addition, one company can acquire stock in another company without approval of its stockholders; mergers and consolidations typically require stockholder approval. Holding companies and their subsidiaries are considered separate legal entities, so that the assets of the parent company and the individual subsidiaries are protected against creditors' claims against one of the subsidiaries. However, holding companies and their subsidiaries may be considered a single economic entity, and consolidated financial statements are then prepared for the entire structure.
Los Angeles, CA and Boston, MA – January 5, 2016— NantWorks, and its majority-owned subsidiary NantHealth, LLC, a cloud-based information technology provider combining genomic science and big data to transform healthcare, today announced that they have completed the acquisition of NaviNet, Inc., the nation’s leading healthcare technology company of payer-provider collaboration solutions.
rdy: It is not hard. KEYO will never trade again. Done.
Which means you can never sell your KEYO shares. Which means they are worthless.
What I don't get is why anyone wants worthless shares. Why do you want to be permanently 'locked in?'
And let the TRUTH be known!
However, Comprehension is required to - GET IT!
pt - LMAO!!!
I don't get it.
RDY: Even Mr. Hes said KEYO won't trade again. So how does former KEYO 'investors' win? I don't get it. How do owners of a stock that will never trade again ever get their capital back?
Ahhhh....amazing when comprehended correctly and NOT hearsay misleading rubbish!
ROCK On NANT/KEYO Shell!
s3l: Even if someone requested that the State of Delaware revoke the dissolution, KEYO would not start trading again. The only issue on which Lesn and I agree is that KEYO will never trade again.
Interesting... Been wondering why the shares still show up in my account. Wouldn't that be something! Haha:)
Popt: AGAIN, THANX FOR THE RE-PLAY!! LNS_EOM
Popt: NO IT'S NOT. YOU'RE WRONG. LNS_EOM
Popt: Thanx for re-posting that again. lns_eom
lesn:
Tom has long claimed was he did three years earlier to the status date. That's 100 wrong
After all, they told the world they voluntarily liquidated and dissolved Keyon Communications, Inc. in 2012...
He unequivocally stated that the notice applied to ALL ENTITIES.
Popt: The status date in the report I pulled is clearly for the day of the dissolution, not the date of the filing of the certificate of the dissolution - which Tom has long claimed was he did three years earlier to the status date.
That's 100 wrong and not the way the status date is used.
Really, just think about it.
When a company decides it wants to dissolve, how does it INITIALLY inform the state and the PUBLIC?
A company can't fully dissolve overnight. We all agree, it's a process, like anything else. There are steps to it. So, How would one know that a company is going through that process if their status shows 'GOOD STANDING'?
The company is dissolving, so wouldn't that be wrong to show it as 'GOOD STANDING' all during that dissolution process and period? Yes, it would be. And, guess what, Popt? THE STATE OF DELAWARE AGREES WITH ME!
Here, from the State of Delaware's VERY OWN website...
https://icis.corp.delaware.gov/Ecorp/FieldDesc.aspx
STATUS
...
D - Dissolved - A certificate of Dissolution has been voluntarily filed by the corporation to terminate its legal existence.
lesn: During the 3 year period before the dissolution, the status is 'cancelled.' The status date is for the status and the current status is 'dissolved.'
https://www.delawareregisteredagent.com/how-to/revive-delaware-corporation
Thanks SO MUCH for posting that. Makes it easier for me. Everyone read this slowly and comprehend. https://www.delawareinc.com/corporation/how-to-dissolve-delaware-corporation/ A Certificate Of Dissolution must be issued by the state of Delaware IN ORDER TO formally dissolve a company. (This clearly indicates that the official issuance of a certificate of dissolution is the FIRST STEP to formal dissolution of a company). It is important to note that the documentation must be signed by an officer of the corporation. After it is signed and returned to us by mail, email or fax, the certificate of dissolution will be filed with the state of Delaware within 24 hours. Thus....if a certificate of dissolution is the first step in formally dissolving a company, the 3 year winding up period begins as of the STATUS DATE showing in the Delaware Certificate showed so brilliantly in your post. Thumbs up.
Popt: More undeniable TRUTH and FACTS...
http://bankruptcy.cooley.com/2015/02/articles/the-financially-troubled-company/you-say-you-want-a-dissolution-an-overview-of-a-formal-corporate-wind-down/
A Corporation In Dissolution. Under Delaware law, once the dissolution commences the corporation is no longer permitted to operate as a normal business. Instead, as the Delaware statute provides, the corporation continues only “gradually to settle and close their business, to dispose of and convey their property, to discharge their liabilities and to distribute to their stockholders any remaining assets, but not for the purpose of continuing the business for which the corporation was organized.” The corporation is allowed up to three years to complete the dissolution process; if more time is required, a request has to be made to the Delaware Court of Chancery (although a corporation in dissolution remains in existence, without having to go to the Chancery Court, to complete lawsuits that are pending when the three year period expires).
Popt: Notably, THE TRUTH IS, the status date IS the date the Certificate of Dissolution was filed AND ACCEPTED by the State of DE which only THEN STARTS the THREE-YEAR DISSOLUTION PERIOD.
THE TRUTH...
§ 278 Continuation of corporation after dissolution for purposes of suit and winding up affairs.
All corporations, whether they expire by their own limitation or are otherwise dissolved, shall nevertheless be continued, for the term of 3 years from such expiration or dissolution or for such longer period as the Court of Chancery shall in its discretion direct, bodies corporate for the purpose of prosecuting and defending suits, whether civil, criminal or administrative, by or against them, and of enabling them gradually to settle and close their business, to dispose of and convey their property, to discharge their liabilities and to distribute to their stockholders any remaining assets, but not for the purpose of continuing the business for which the corporation was organized. With respect to any action, suit or proceeding begun by or against the corporation either prior to or within 3 years after the date of its expiration or dissolution, the action shall not abate by reason of the dissolution of the corporation; the corporation shall, solely for the purpose of such action, suit or proceeding, be continued as a body corporate beyond the 3-year period and until any judgments, orders or decrees therein shall be fully executed, without the necessity for any special direction to that effect by the Court of Chancery.
Sections 279 through 282 of this title shall apply to any corporation that has expired by its own limitation, and when so applied, all references in those sections to a dissolved corporation or dissolution shall include a corporation that has expired by its own limitation and to such expiration, respectively.
Popt: No. It causes KEYO to not be fully dissolved and simply in the MIDDLE of the dissolution period.
If it were fully dissolved and no longer a company then I wouldn't still have KEYO shares in account. It's that simple.
AFTER May, 2017, IF KEYO still (for some outlandish reason) still has not been used by Dr.SS to affect his RTM w/ NANT, THEN you can claim it to be fully dissolved and not a public shell any longer.
It is a non-reporting, non-trading shell needed in the plan fo a RTM w/ KEYO being the PUBCO in the transaction to take the PRIVCO, NANT, public AFTER the transaction. AFTER the transaction, KEYO will no longer exist at all as a company and NANT will occupy KEYO's former public shell and trade on the NASDAQ.
The WHOLE truth is, Popt, that Tom W. said he formally dissolved the company in 2012. But, it wasn't until 18 months later when only THEN did he file the cert of dissolution w/ the State of DE SOS which only then OFFICIALLY STARTS the THREE-YEAR DISSOLUTION PERIOD. Your entire argument completely leaves out that KEY FACT.
No, I'm not saying Tom and Soon-Shiong are lying at all. And that is a GOOD thing!
lns
heidi: The status date in the report I pulled is clearly for the day of the dissolution, not the date of the filing of the certificate of the dissolution - which Tom has long claimed was he did three years earlier to the status date.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120984947
Which means you can find the real certificate of dissolution on this board.
No. He did not make that up.
hes: You just made all that up but it was creative. Thumbs up.
S3lf: Nobody has any tables open. lns_eom
Wrong. Dissolution is a process. The status date pertains to the date all fees were paid and the dissolution was authorized. There is also a 3 year window to revoke the dissolution. In the meantime the corporate shell continues to exist for the sole purpose of marshalling assets and winding up the business. During that dissolution period, a reverse merger with a successor entity can take place. Which is why Delaware has so many laws pertaining to successor entities and obligations. More DD is needed :)
lesn: Notably the status date is not the filing of the certificate of dissolution. The status date is for the dissolution itself - which is three years after Tom said he dissolved the company.
Dang, folks still around I see... I Have some chips but no tables open
lesn: It causes KEYO to be dissolved and not public. It is not a public shell needed in the scan of a RTM with KEYO being the publicly traded company. Tom said he dissolved the company in 2012. Three years later, the SOS shows the company is completely dissolved. Your entire argument is the both Tom and Soon-Shiong are lying and that is a good thing!
Popt: Let me clarify as I see it might need it, w/ a few questions...
1) What does the 'Status Date' indicate?
2) What is the time period given for a company to fully 100% dissolve in the State of DE?
3) What is the Status Date of KEYO's latest State of DE Entity Details?
4) Based on the above, when is the end of the dissolution period slated for KEYO do be considered fully dissolved (if the market blew up and Dr.SS hadn't still gone public)?
5) Is KEYO reporting?
6) Is KEYO trading?
7) Based again on the above, as of this very moment, what does all that cause KEYO to be considered?
lns
Popt: Read up on the law. The three-year dissolution period only SIGNALS THE START of that three-year dissolution period.
The State of DE only has the one designation for it from start to finish of the three-year dissolution period..."Dissolved". One only has to know the law and look at the date the cert was accepted by the state. That date starts the three-year dissolution period.
Based on that, how do you think one goes about figuring out when the three-year dissolution period ends?
Look there. I see it. Do you? It's in RED even...
05/22/14
lns
lesn: There are 'percent' dissolution laws in Delaware and the SEC says the KEYO is not longer a company. Delaware is showing Keyon as dissolved.
However, you indicated KeyOn Communications Holding had its corporate charter dissolved by the state of Delaware. Please be advised once a company’s charter has been dissolved by the state, the [former company] is no longer licensed and ceases being a legal business entity.
Sincerely,
Rinell Randolph
Attorney
Office of Investor Education and Advocacy
U.S. Securities and Exchange Commission
Popt: I saw why he said that. He said that because a little, VERY IMPORTANT fact was left out of the explanation to him. The FACT that KEYO is NOT 100% DISSOLVED.
It, AGAIN, is in the MIDDLE of the THREE-YEAR DISSOLUTION PERIOD, thereofore...
KEYO STILL IN PLAY!
I've seen this be an issue before...facts omitted which allows for confusion to work its way in.
lns
Popt: My gosh. THAT AGAIN! ROTF! lns_eom
lesn: I was just posting what an attorney at the SEC clearly stated: Keyon is no longer a company.
However, you indicated KeyOn Communications Holding had its corporate charter dissolved by the state of Delaware. Please be advised once a company’s charter has been dissolved by the state, the [former company] is no longer licensed and ceases being a legal business entity.
Sincerely,
Rinell Randolph
Attorney
Office of Investor Education and Advocacy
U.S. Securities and Exchange Commission
lesn: If it was voluntary. And as Tom said, he voluntarily dissolved Keyon in 2012.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120503922
https://onedrive.live.com/?cid=2e8c78c71cc13f2d&id=2E8C78C71CC13F2D%21109&authkey=%21AI6j-5HKs8bLT14
2012+3=2015 the company would be completely dissolved. Forever. Done. Gone.
I mean come on. Why would Soon-Shiong let his public company in a RTM stop trading in the same year he wanted to take Nanthealth public?
A: He wouldn't.
Popt: How many times do we have to go over this same thing?
Again, KEYO is in the MIDDLE of the THREE-YEAR DISSOLUTION PERIOD given for a company to wrap up EVERY LITTLE THING they need to. In other words, all loose ends. Or, do anything else they want to w/ it w/in that THREE-YEAR DISSOLUTION PERIOD. The filing of the cert only STARTS that three-year clock.
What more do you need to accept that KEYO is a non-reporting, non-trading shell company that is still viable for the completion of an RTM? Which, IMO, Dr.SS is SOON to finalize w/ the exchange of shares between PUBCO and PRIVCO to take PRIVCO public.
lns
Popt: A shell is a company. Keyon is a shell.
None of what you claim were my factual positions. My factual position on this subject has always been the above and below...
A shell is a company. Keyon is a shell.
Ergo, Keyon is a shell company.
To specify, Keyon is a shell company that is in the middle of the three-year dissolution period offered by the State of DE.
To further specify, Keyon is a non-trading, non-reporting shell company that is in the middle of the three-year dissolution period offered by the State of DE.
One can go back to 5/14 here and re-read all the facts that address every one of your concerns. Heck, one just has to go back a month and it's all been repeated a dozen times since then already. Do we need to add more?
lns
lesn:
However, you indicated KeyOn Communications Holding had its corporate charter dissolved by the state of Delaware. Please be advised once a company’s charter has been dissolved by the state, the [former company] is no longer licensed and ceases being a legal business entity.
Sincerely,
Rinell Randolph
Attorney
Office of Investor Education and Advocacy
U.S. Securities and Exchange Commission
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117741452
Translation: Keyon is no longer a company. It has no officers. It has no address. It has no board. It has no agent. The only argument left to make is that it is a 'illegal business entity.' Hey! That would work.
Popt: KEYO is a NON-TRADING, NON-REPORTING shell. A type of shell that indeed FACTUALLY CAN be used to affect a RTM.
This is an uncontested fact by those who know and practice theses laws.
http://www.reversemergers.com/about/
lns
lesn: KEYO is not a shell. It is not a company. It is not public. These are uncontested facts.
Your first quote has nothing to do with a shell. It is discusses a corporation. Keyon is not a corporation.
Your second quote discusses a corporation trading.
KEYO is not trading.
All of this means: KEYO is not a shell. It is a scam.
Popt: Depth is lacking in your analysis. Not one shred of evidence has been presented by anybody, including yourself, that proves a NON-LISTED, NON-TRADING PUBLIC SHELL cannot be used to affect a RTM.
Non-Trading, Non-Reporting
A corporation that is not trading nor reporting typically only has a shareholder base. No stock symbol is registered and the company may or may not have once been a reporting company.
Non-trading and non-reporting corporations must file with the SEC before becoming a reporting company. Filing means a full company audit as well as filing a new 15c211 with the NASD to get a stock symbol. Because of the nature of these types of shells, we typically stear away from them
6. What are the shell’s trading patterns in and during the
transaction?
If shell management and their friends begin trading in and out of the stock before major announcements, this is not just their problem. The company itself could be sued on an “alter ego” theory of insider
trading. This illustrates one of the advantages of working with a non-trading shell.
watch:
1. Cleanliness of the shell. Really, that's the big one. It MUST be a clean shell.
lesn: No, it is just that all the facts have gotten in the way of the scam. Everything about the scam has been debunked. Everything.
What good is a Tax Free merger to the Doc
if he has to share the booty with an iHub buyers group?
He doesn't own 100% of the shares of the former KEYO correct?
He would own 100% of a newly formed corp, though
SMF: In doing some research and educating myself about this a bit, I found several reasons I think a RTM would fit this man better than a traditional IPO. Forget the KEYO theory and just think about an RTM over an IPO for Nantworks / Nanthealth. Let me know what you think of these possible reasons...
PROs of the RTM:
1. The operating business remains completely intact. Bank accounts, employer ID numbers, all contracts and leases all remain the same because only the ownership of the private company changes. This, to me, would be huge for PSS. Imagine how many contracts, employees, bank accounts, etc. that he has between all of the companies we're talking about here? If he RTM's Nantworks, it would be a seamless transition.
2. Cost. Much lower than an IPO. Tax free if set up correctly.
3. Faster. Not that big of a deal if you ask me.
4. Lack of an underwriter. In an IPO, an underwriter almost HAS to be part of the process. When the happens, they often suggest or insist that the company raise more money in the offering than it needs. In an RTM there's no underwriter.
5. Lower dilution of control. As a by product of not having an underwriter, the management can control the number of shares released and a higher percentage of ownership can remain with the top brass.
CONs of the RTM.
1. Cleanliness of the shell. Really, that's the big one. It MUST be a clean shell.
2. Raises less money than an IPO.
So, for PSS, as already the richest doctor in the world, do you think him going public is about more money for him, or something else? I think he's interested in the liquidity that being public offers, and there was also something about Nanthealth being in some sort of trust? I forget. But either way, it seems a RTM might be a better option than a traditional IPO. Do you agree or disagree? KEYO theory aside, would this not be a better way for him to go public? An RTM isn't always a better option but for this guy and what he's doing? It seems smarter to me.
I'm not part of any buyers group, but I did pick up a couple hundred shares. No matter what he does, IPO or RTM, the moment he makes shares public, he's going to be sharing his booty with other people. So whether it's a buyers group or some large corporation, or some dude from Kansas with money to burn, it doesn't matter. It won't be 100% his anymore. But with the RTM, he can control just how much of it remains his.
How does KEYO fit? The biggest/ pitfalls of an RTM is with the cleanliness of the shell, right? Well, what if the shell is a company you owned and set up in such a way as to seamlessly provide you with a vessel for this transaction? Away goes the biggest problem.
I still think it's a long shot. Really I do. Primarily because you can't predict the future and what seems good on paper often doesn't materialize, but an RTM with KEYO does make some sense.
I'm not an expert in all of this, so I'd appreciate some feedback.
Thanks.
Popt: Problem. No Clue, Man. Simplistic thinking. lns_eom
Popt: As mentioned, I think deeper than the surface and I know words have meaning and I acknowledge all of them. We placed bets. FORBES confirmed the DD. We placed more bets. Why does that bother you?
lns
lesn: No problem, Your Clue Man is here and will help to get you right!
-Soon-Shiong has never said he wants to use tracking stocks.
-Soon-Shiong has never said he is using tracking stocks.
-Soon-Shiong certainly never said he was doing a RTM.
-Soon-Shiong has never said he was taking Nantworks public.
-Soon-Shiong has never said KEYO will be used for taking anything public.
-Soon-Shiong did say he was planning an 'IPO' for Nanthealth.
-With NK, Soon-Shiong showed he really likes a nice IPO. The original launch piled on another $1B to his fortune. Much of that is gone.
-Forbes, despite all the name dropping, has never confirmed any part of Soon-Shiong doing a reverse triangular merger. They have only said it will be an IPO. Like Soon-Shiong said!
-A reverse triangular merger, even tax-free, needs a nice publicly traded shell company.
-A RTM can be announced in advance.
-KEYO is not traded so it is impossible to have insider trading!
-Nantworks is not traded so it is impossible to have insider trading!
-Soon-Shiong let Keyon dissolve. From your suggestion, he volunteered to dissolve Keyon! Fired up about it!
-Soon-Shiong let KEYO stop trading in the same year he planned to IPO Nanthealth.
-KEYO is no longer a company.
-KEYO no longer trades publicly.
-Therefore, KEYO is not a publicly traded shell company.
-Therefore, KEYO cannot be used in a RTM.
The days of 'zero clues' are over! You are, now, caught up and a nice wrap up for the weekend.
Insert_EOM
Popt: Zero clue. That's all wrong. lns_eom
lesn: Soon-Shiong has never said he was using tracking stocks but I don't see the relevance even if he did. The NK IPO suggests Soon-Shiong is not using NantWorks as the parent in a very-90s tracking stock scheme. I do get the idea that this looks like an informal tracking stock plan with NK being included. So far, these Nant relationship have been very incestuous which I think has hurt NK.
However, all that is irrelevant to whether a non-public dissolved company, KEYO, can be used as the publicly trading arm of a RTM deal. Obviously, they can't.
I don't have 'claims' unless you mean patent claims. And then, I have thousands of those.
Followers
|
75
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
10055
|
Created
|
10/18/08
|
Type
|
Free
|
Moderators |
**********ALERT: KEYO (DE Corp) shell 80% OWNED BY BILLIONAIRE DR. PATRICK SOON-SHIONG....DISSOLVED 5/22/14 AND IS NOW A CLEAN SHELL******
http://images.investorshub.advfn.com/images/uploads/2014/7/6/nufezKEYO_DE-status.JPG
http://www.nantworks.com
In 2011 Dr. Patrick Soon-Shiong invested in KEYO to build out his national healthcare dream. The company was poorly run and Shiong took control, leaving it as a shell for his use. At the same time, he managed a Leveraged BuyOut of the National Lambda Rail. They needed cash, and the $100M he gave made him the control. Its the NLR that supports most of the Nantworks family of companies today.
http://www.flinn.org/news/1015
"KeyOn Communications’ largest and controlling shareholder is California Equity LLC, an entity controlled by Dr. Patrick Soon-Shiong. Dr. Soon-Shiong, having built and sold two multi-billion dollar pharmaceutical companies in the past few years including Abraxis BioScience to Celgene Corporation (NASDAQ: CELG), is a physician, scientist and philanthropist who has made clear his intention to develop a comprehensive “health information highway system” throughout the United States. "
Soon-Shiong, 62, has a lot to show. First, he walks him through a mock-up of a futuristic hospital room: There’s a patch that measures a patient’s heart rate, temperature and blood pressure, and a 3-inch white cube, called an HBox, connecting every device to a computer network. He shows off a darkened room covered in computer screens: a control center from which a handful of doctors can monitor hundreds of patients, even when those patients are at home. And finally he calls up several computer programs that make sure doctors know, up to the latest scientific-journal article, the best treatment available. It’s a sweeping assemblage of data-driven toys–fueled by $1.3 billion worth of furtive acquisitions, almost entirely using Soon-Shiong’s own money.
This dizzying demonstration wows Sanford, who seems extra-rumpled next to Soon-Shiong, in his crisp tailored blue shirt and suit pants, which he fills sleekly (he owns part of the Lakers and plays hoops regularly on an indoor court at his house). “I think it’s exactly what we need in this world,” Sanford says. “I also have a hospital group. I think we’re at 40 hospitals and 150 clinics, but costs are just going crazy, and the lack of communication between these organizations is just paramount to correct.” Soon-Shiong jumps in for the close: “The hospitals aren’t organized, funded or even have the skill sets to create this kind of communications infrastructure. Frankly, the government should have done it.”
As evidenced by the incompetent ObamaCare rollout, perhaps it’s better that Soon-Shiong did, and Sanford is taking whatever this doctor prescribes. They shake hands eagerly on a deal to deploy the technology at a children’s hospital in Phoenix, Ariz.
Even after the demonstration, though, exactly what Sanford is buying remains unclear. As seen over Soon-Shiong’s shoulder, the demos look fantastic. But no outsider I spoke to had actually laid hands on all the pieces of the technology. There is no real business plan. No pricing model. All they have is Soon-Shiong’s word, which is a tricky thing. While he’s undeniably brilliant, Soon-Shiong is equally undeniably a blowhard, a view shared widely across the medical spectrum (his Twitter TWTR +4.17% handle:
@solvehealthcare). “The marketing is three years ahead of the engineering,” says John Halamka, one of the first people to ever have his genome sequenced and the chief information officer of Beth Israel Deaconess Medical Center in Boston. “What works on paper, what works in the lab and what works in a complex academic medical center are very different things.” He later adds: “Patrick is a showman of sorts, and for him to claim, ’I have solved the problems that everyone else over the last 20 years hasn’t been able to solve…’ ”
It bothers me, too. Soon-Shiong’s sparkling headquarters, a futuristic amalgamation of metal and glass where some of his 800 employees scurry about, sits in L.A.’s Culver City neighborhood, which has birthed dozens of Hollywood fantasies, including The Wizard of Oz. Accordingly, I’ve spent the past ten months trying to pull back the curtain. Soon-Shiong has allowed me an exclusive, detailed look inside his efforts–the Manhattan Project of medicine–just as he was closing the deal that will see them put into action for the first time at Providence Health & Services, a 34-hospital, not-for-profit Catholic health ministry in Oregon, California, Alaska, Washington State and Montana. And I talked to dozens of outsiders.
What was universal: the scope of Soon-Shiong’s undertaking. “When we went to see him and got a look at what they’re planning to implement, we were dazzled,” says Gillies McKenna, head of the department of oncology at Oxford University. “If you can make this work, and I agree it will be very difficult, he’s looking at an exponential increase in the amount of data we can base decisions on.” Soon-Shiong explains it this way: “We will have more information at our fingertips than we ever had in the history of mankind–every day. Not once a month, a week. Every day.” Such omniscience has the potential to reverse the perverse incentives–which emphasize treatments rather than results–driving America’s annual health costs past $3 trillion. It could also cure most of what ails us, even cancer.
Soon-Shiong is accustomed to doubters, as the son of Chinese immigrants in apartheid-era South Africa. He graduated high school at 16 and medical school at 22. His first patient, an Afrikaner, refused to be touched by him, but after Soon-Shiong drained his infected sinus, he told everyone, “That Chinaman. Make sure you get him to examine you.”
Soon-Shiong left South Africa in the late 1970s and arrived at UCLA in 1980. Stephen Nimer, a hematologist who would later serve on the board of directors for one of Soon-Shiong’s companies, remembers him as an “unbelievable surgeon” who was always willing to take on the most difficult cases. “It’s in his blood to help people,” Nimer says.
So is a deep streak of P.T. Barnum showmanship–and a talent for pissing off investors and colleagues alike. As a surgeon at UCLA he grabbed headlines transplanting insulin cells into a diabetic. The president of the American Diabetes Association called it “inappropriate hype,” saying it was “far too early to view this as a cure or even a therapy.”
In 1990 he started a company to commercialize his diabetes work and got a deal with Mylan to explore transplanting pig organs into people but backed out because he decided it might be unsafe. He ended up in a legal feud that included, among others, his own brother.
Then, in 1991 he invented the drug that made his fortune: Abraxane, which packages the top-selling cancer drug, Taxol, inside the protein albumin. The idea was that tumors would eat the albumin and get the poison.
Top oncologists called it “old wine in a new bottle.” But Soon-Shiong was convinced he was on to something big. He decided on a novel–and personally risky–approach to fund Abraxane’s development. Rather than sell stakes to venture capitalists, the traditional route to bankrolling biotech research, he instead took out loans to buy a small, publicly traded generic drug business, which he renamed American Pharmaceutical Partners, folding his Abraxane initiative inside it. A physician buying group, which purchased drugs from APP, invested in it. Some said this was a conflict of interest; Soon-Shiong says the group contributed to help prevent drug shortages and sold its shares as soon as APP went public. But his reputation had been dinged again.
In 2005 he won a huge victory: The FDA approved Abraxane, defying short-seller interest, which ran as high as 100%. Shares jumped 47%. But once again Soon-Shiong became the center of controversy when, a few months later, he merged APP with a private vehicle he owned. Brian Laegeler, an analyst at Morningstar, called it a “raw deal for minority shareholders as it serves only to line the pockets of Patrick Soon-Shiong.” The stock dropped 18% the day the deal was announced. Soon-Shiong says the long-term rise of the shares vindicated the move.
Then in 2007 the stock soared again. The firm was the only maker of the blood-thinner heparin whose product did not have to be recalled because of contamination that killed 81 people. Soon-Shiong split and sold the company, saying it was “two unique businesses.” The generics business, including heparin, went to Fresenius in 2008 for $4.6 billion. In 2010 the drug business, Abraxis, was bought by biotech giant Celgene for $4.5 billion. Soon-Shiong owned some 80% of each.
Another multibillion-dollar windfall soon followed. Despite Soon-Shiong’s insistence that Abraxane was “a breakthrough,” by 2011 sales were just $386 million–a middling success in the booming biotech sector. Then last year a study showed the drug extended the lives of pancreatic cancer patients by 1.8 months. Sales jumped 90% and are projected to hit $2 billion by 2017. Celgene’s stock–Soon-Shiong remains the largest individual shareholder–surged in lockstep.
Cleverness, determination and luck had left Soon-Shiong with enormous wealth–we put his current net worth at $12 billion. But it also left him with a reputation as more of a wheeler-dealer than a scientist, which pains him, say confidants. “He has recognition in the business community,” says Michael Crow, the president of Arizona State University, another institution Soon-Shiong is talking about working with. “But that’s very different from the recognition that this was the man who built the intellectual fabric that allowed cancer survival rates to be increased 80%.”
The HBox can connect every device in a hospital room to the cloud.
Soon-Shiong’s grand new project promises the closest thing that Earth has ever had to Star Trek’s fabled tricorder. In theory it will work like this: A cancer patient will arrive at the hospital for diagnosis. Everything from her DNA to the proteins in her blood will get instantly analyzed via a proprietary and superfast network, with the data collected automatically in real time–no pens, paper or clipboards. Within minutes computers will recommend which drugs to try. Once the patient is sent home, the same technology will travel with her, allowing doctors to continue to monitor her in real time, as hospital administrators evaluate the efficacy and costs of various procedures and medicines and compare notes with hospitals across the country.
This vision came during the approval process for Abraxane in 2005. Doctors were making bad decisions. One study found that two-thirds of pancreatic cancer patients received the wrong treatment. Computer brainpower wasn’t enough to fix this, Soon-Shiong realized, if it wasn’t paired with a high-tech nervous system. “How could we ever hope to win the war against cancer using our newly gained molecular insights against a disease that has the capacity to constantly change and mutate?” he says.
Like a mechanic rummaging for parts, he started buying companies to build his new machine. He grabbed Eviti, based in Philadelphia, which sold its services to insurers as a way to ensure that cancer doctors weren’t prescribing medicines improperly (and billing for their errors). Thirty oncologists and nurses pore over the latest medical journals to make sure the information is up to date.
Another purchase: iSirona, a firm in Panama City, Fla. that’s attempting to connect hospital machines with electronic health record systems. Soon-Shiong now claims that it can integrate 6,000 different medical devices, including pulse oximeters, blood pressure monitoring devices and bathroom scales, as well as hundreds of different types of clinical and financial software from every major medical vendor.
There were other technologies, too: Qi Imaging, a tool that allows CAT scans and MRIs to be viewed on mobile devices; GlowCap, an $80 pill bottle that lights up when patients at home need to take their medicine and lets doctors know they are opening the cap. He purchased and refurbished the National Lambda Rail, a high-speed government computer network, at a cost of $100 million, so all this data could move quickly from place to place. “In order to have value-based care you need to monitor outcomes in real time,” says Soon-Shiong. “And you need to monitor cost in real time. You’re going to have patient-centered highest-quality care at the lowest cost.”
All of these pieces–and dozens more that he’s bought or built–combine into a corporate structure as byzantine as his overarching product. His 800 employees are splintered across offices in 14 cities, and NantWorks, the parent holding company, houses nine separate units, all with different investor groups and each apparently designed to trade independently as a tracking stock. The first IPO, as early as next year, will likely be NantHealth, his health care information technology play, poised to profit from new payment schemes created by ObamaCare. Investors include Verizon, Celgene, BlackBerry and the Kuwait Investment Authority. FORBES values NantHealth alone at $1.6 billion. All told, FORBES values the entirety of Soon-Shiong’s Nant-related holdings at $7.7 billion.
The potential and pitfalls of Patrick Soon-Shiong’s medical Manhattan Project boil down to one statistic: 47 seconds. That’s the amount of time, the doctor/entrepreneur promises, it now takes for his amalgamated “supercomputer” to complete genomics analysis, all the way to identifying the individual protein in someone’s body that’s amenable to drug treatment. “It normally takes 11 weeks,” Soon-Shiong smiles.
Like so much he says, it’s a stunning statement with infinite promise. And an unverified one of the kind that makes Soon-Shiong polarizing.
When Soon-Shiong dramatically and fantastically described his platform in public for the first time, at the Forbes Healthcare Summit in New York last October, the preeminent doctors, scientists and health care executives in attendance ranked him the top speaker of the event (95% of attendees surveyed rated it good or excellent). Yet many of them were confused (#stilldontgetit, tweeted Halle Tecco of Rock Health, who runs an incubator for health IT companies) or skeptical (“It’s an avant-garde idea–and one that will be delivered in pieces,” said N. Anthony Coles, the former chief executive of Onyx Pharmaceuticals). Johns Hopkins professor (and Forbes.com contributor) Steven Salzberg, pondering the 47-second statement, posited: “What does that even mean?”
For the sake of clarity and credibility, I spent a disproportionate amount of my time over the past year focusing on his oft-repeated 47-second pledge. It turns out to be profoundly misleading because it is an average time, not the time for an individual. It’s like saying McDonald’s can hand you 800 Happy Meals the instant you pull up at a drive-thru window because the company serves 800 meals a second worldwide. The real question is: How fast can an individual patient’s genome be analyzed? Pushed, Soon-Shiong says he is aiming for 24 hours for each patient.
That’s still astoundingly fast. David Feinberg, the president of UCLA Health System, confirms that he got data back on cancer patients within a couple of days. Randy Axelrod, an executive vice president at Providence, where the Nant system will soon roll out, says he sent in DNA sequences from several patients and had them back within hours.
A bake-off by Genomics England, a government project that hopes to sequence 100,000 Britons, found that Nant was one of the few platforms that could consistently sequence cancer genomes quickly.
Even more impressive, Soon-Shiong says–and a number of experts believe–that he can already analyze 500 genomes a day, on par with the world’s most advanced DNA research centers, and will be able to do 4,000 a day by the end of next year. And Nant can move these huge sets of data to any hospital on his network almost instantaneously.
Which raises the question: Why the unnecessary, counterproductive hyperbole? How easy it could have been to instead take a bow for the hardware and the high-speed data connections he has built.
And why compare your time against another (11 weeks) that no longer seems to exist? “Our best shot with software that’s proprietary is 15 minutes, and then there’s still plenty of work to be done,” says Eric Topol, the chief academic officer at Scripps Health. Ultimately, whether you can do it in 47 seconds or an hour or five isn’t really what’s important. Accuracy and cost are.
Soon-Shiong angrily shrugs off the criticisms. “Unfortunately, when you go outside the accepted conventional bounds, some people feel threatened and strike out,” he says. “When you run a public company, short-sellers seize on it and give it even more legs. Fortunately, the strong persevere–and not just me–and we have a better world for it. If they didn’t, a lot of advances in health care, science and technology would never be achieved.”
Soon-Shiong’s chance to silence the doubters will soon begin. “You’ve got these fantastic ideas; you’ve got these fantastic people,” says Jim Davies, the chief technology officer of Genomics England. “Now is the bit where they roll it out.”
At St. John’s, an L.A. hospital to which Soon-Shiong has given $85 million, a prototype of a system is tracking patients’ treatments and what they cost in real time. And a full-scale deployment of Nant’s systems will roll out imminently at Providence Health & Services, which acquired St. John’s. Soon-Shiong met the system’s CEO, Rod Hochman, during the deal. They hatched the idea for using Providence not only as a testing ground for NantHealth’s software but also for its genetic tests, as it aims to offer them to every one of their 25,000 cancer patients each year.
Cancer is a disease of genetics. It happens when a genetic defect or, more likely, a collection of defects causes cells to go haywire and grow out of control. By identifying which genetic defects are present, and picking drugs to target them, doctors may be able to treat otherwise untreatable cancers.
Soon-Shiong has an example, identified using Nant technology. A woman was suffering from cervical cancer and had had her genome sequenced. When it was fed into Nant’s computers, they found that the human papilloma virus, which causes the cancer, had inserted itself into a gene called Her2. This is the target of the breast cancer drug Herceptin; when the woman was given Herceptin, a drug that would normally not be used for treating cervical cancer, her tumors shrank.
It’s a great story. But again, hype blurs the brilliance. Nant’s analysis had a wonderful result for the patient, but it’s hardly a medical breakthrough or even unique: Foundation Medicine, a cancer-genetics startup backed by Bill Gates and Google Ventures, has touted a case where cancer in a woman’s colon shrank because of a lung cancer drug.
As with everything in Big Data, what Nant brings is scale. Where Foundation Medicine tests patients’ tumors for mutations in 343 genes, Soon-Shiong plans to do 260 times more: sequencing the whole genome of the patient, the whole genome of the cancer (which is genetically distinct) and the chemical messages, known as RNA, generated by the cancer genome. Even with the use of DNA sequencers, this will cost $3,000 per patient just for sequencing, and it will take three days, plus another day for analysis. Providence expects to pay for this in part by getting insurers to pay for it.
In the end the most telling statement may have come at the Healthcare Summit from Susan Desmond-Hellmann, who watched Soon-Shiong’s rise when she ran clinical development at Genentech before becoming chancellor at the University of California, San Francisco and then CEO of the Gates Foundation: “Don’t underestimate him.”
“Deep down,” says ASU president Crow, “he knows that being the world’s richest doctor is not the check that he wants by his name. It’s insufficient.” “My quest was and is to improve the quality of life through science,” adds Soon-Shiong. “That is what drove me then, and that is what is driving me now.” The bad blood will mean nothing if he’s successful–and it seems very likely, based on a review of his claims, plans and investments, that he will succeed at something. Even a fraction of his grand vision will mean good news for millions of American patients.
http://www.forbes.com/sites/matthewherper/2014/09/10/medicines-manhattan-project-can-the-worlds-richest-doctor-fix-health-care/
http://www.forbes.com/profile/patrick-soon-shiong/
ANSWERS TO QUESTIONS BELOW
More New Information from September 2014
http://www.healthinnovationcouncil.org/wp-content/uploads/2014/09/BPC_Health-Innovation-Initiative_Building-Better-Health-A-Report-from-the-CEO-Council-Sept-2014.pdf
Building Better Health: Innovative Strategies from America’s Business Leaders: the Bipartisan Policy Center was founded in 2007 by former Senate Majority Leaders Howard Baker, Tom Daschle, Bob Dole, and George Mitchell, the Bipartisan Policy Center (BPC) is a nonprofit organization that drives principled solutions through rigorous analysis, reasoned negotiation, and respectful dialogue. With projects in multiple issue areas, BPC combines politically balanced policymaking with strong, proactive advocacy and outreach.
This report outlines the many ways in which our companies are working to improve health and well-being as well as the quality, cost, and patient experience of care.
From page #103 - The Overview and Appendix A and Summary supplies answers to questions of how Dr. Patrick Soon-Shiong will change the face of Healthcare Worldwide.
(following content edited due to space limitations - all can be found under headings in full report at link above)
Overview
With the poorest outcomes and highest cost compared with the industrialized world, the health care system in the United States is failing. According to a 2014 independent Commonwealth Fund report, the United States ranks last among 11 industrialized countries on health care quality and access, despite having the costliest care. The report ranked the United Kingdom first overall, even though its per- capita health spending is less than half that of the United States. The information highway portion is tied in with Keyon Communications Holdings, Inc. thusly:
Grid-computing is a technology model designed to promote the coordinated sharing of resources in dynamic, multi- institutional virtual organizations. Grid-computing focuses on the loose coupling of data and services. This approach allows different institutions to come together to achieve
a particular goal while still maintaining local autonomy in issues ranging from information system architecture to institutional policy to patient privacy. This flexibility and focus on controlled sharing makes grid-computing particularly well suited to address the complexity of the fragmented health care system.
This infrastructure allows for the interoperable, secure sharing of health care data between institutions that likely have different information systems and policies. The IAH infrastructure is open to third-party end-user applications, including NantHealth applications, which will form a seamless ecosystem of functionalities that together create a distributed “virtual” longitudinal health record platform. Rather than trying to consolidate health data into physical databases, this “virtual” electronic health record will allow data to be stored locally and to be assembled and accessible in a dynamic fashion.
Paving a Medical Information Superhighway
IAH was established in 2011 with core funding from Dr. Patrick Soon-Shiong and his wife Michele B. Chan, who have pledged through their family foundation more than $1 billion for health care and health information projects. The Institute currently operates in both California and Arizona and is exploring relationships with other states. In March 2011 it announced the funding of data centers in Phoenix and Scottsdale dedicated to health information storage, and also the funding of a dedicated supercomputer for genomic science in Phoenix.
IAH is working with the National Coalition for Health Integration (NCHI) to design and develop this innovative, groundbreaking infrastructure.
NCHI was formed to build a public private coalition of health care partners and academia dedicated to transforming health care by enhancing the availability and integration of health information across the country. In 2011, NCHI provided funding to maintain the viability of the National LambdaRail (NLR), a fiber infrastructure for numerous large research projects including users such as NASA, the National Science Foundation and US institutions connecting with the Large Hadron Collider in Switzerland. The NLR fiber infrastructure was designed for basic science and the physics scientific community. There is now an urgent national need to replace this aged infrastructure of the NLR with a modern fiber network integrated into clinical practices and hospital facilities across the nation and connected to the NCHI supercomputer in Arizona.
Providence Health, NantHealth and the Chan Soon- Shiong Institute of Molecular Medicine partnered in August 2014 to create the country’s first health network for clinical whole genomic sequencing. This health network spans 5 western states and serves 22,000 new cancer patients and 100,000 cancer cases per year. The partnership is installing an Illumina HiSeq X Ten sequencing system to enable the nation’s first clinical whole genome sequencing paired with RNA--\ sequencing and proteomics.
Increasing Access to Care
Leveraging technologies such as low-cost telehealth will increase access to underserved urban and rural areas, in addition to primary care specialties such as pediatrics, where access to neonatologists and pediatricians is deficient. Technology can reduce disparities in health care for everyone.
Establishing a Next Generation National Secure Infrastructure for Big Data Transport
In March 2011 IAH announced the funding of data centers in Phoenix and Scottsdale dedicated to health information storage, and also the funding of a dedicated supercomputer in Phoenix.
A modernized network under construction, combined with existing data centers and supercomputer connections, will enable massive amounts of genomic and proteomic data to be transmitted, analyzed and used to support clinical decisions, thereby improving health outcomes. This infrastructure will help realize the dream of effective, efficient, and truly “personalized” medicine in America.
In Summary
The discovery of “the God particle” (in the Large Hadron collider project) involved the collaboration of hundreds of physicists across the globe, collaborating in real-time by analyzing millions of bits of data. This achievement occurred through the creation of virtual organizations committed to a common cause, utilizing grid-computing and an information highway (the National LambdaRail) for large science projects. This was the motivation and inspiration for the medical information highway.
*** Take the Patents of Tom Wittenschleager, now at NantTronics, and the Rural Broadband developed by Keyon Communications Holdings and overlay with the NLR that Dr. Soon - Shiong owns. The connections appear to point to the KEYO Shell owned by Dr. Soon - Shiong is of value to him******
BILLIONAIRE DR. PATRICK-SOON-SHIONG
1.
NAMES OF REPORTING PERSONS.
Dr. Patrick Soon-Shiong
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,081,734 (See Item 5)
12.
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
Not Applicable
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.2% of the outstanding voting power of the Company (See Item 5)
55.9% of the economic interest of the Company (See Item 5)
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8004537
Nantronics, essentially is the National Lambda Rail
*********President at NantTronics, Inc.**********
KeyOn Communications Holdings Inc. (KEYO.OB)
KeyOn Communications Holdings Inc.
11742 Stonegate Circle
Omaha, NE 68164
United States
Phone: 402-998-4000
Website: http://www.keyon.com
Business Summary |
---|
Quote:
********ALL OF THE CEO'S PATENTS*********
Patents by Inventor Thomas Wittenschlaeger
Patents by Inventor Thomas Wittenschlaeger
Vector-based anomaly detection
Patent number: 8683591
Abstract: Methods of detecting anomalous behaviors associated with a fabric are presented. A network fabric can comprise many fungible networking nodes, preferably hybrid-fabric apparatus capable of routing general purpose packet data and executing distributed applications. A nominal behavior can be established for the fabric and represented by a baseline vector of behavior metrics. Anomaly detection criteria can be derived as a function of a variation from the baseline vector based on measured vectors of behavior metrics. Nodes in the fabric can provide a status for one or more anomaly criterion, which can be aggregated to determine if an anomalous behavior has occurred, is occurring, or is about to occur.
Type: Grant
Filed: February 9, 2011
Issued: March 25, 2014
Assignee: Nant Holdings IP, LLC Inventor: Thomas Wittenschlaeger
Backhaul Fabric For Wireless Network
Application number: 20130308602
Abstract: A managed surface-space network fabric is presented. The surface-space network fabric can include a spaced-based network fabric and a surface-based network fabric integrated together to form a single fabric managed by a global fabric manager. The global fabric manager cooperates with other fabric managers local to each fabric to establish a communication topology among all the nodes of the fabric. Preferred topologies include paths from any port on a node to any other port on another node in the fabric. The surface-space fabric, and each individual fabric, can function as a distributed core fabric operating as a single, coherent device.
Type: Application
Filed: July 23, 2013
Issued: November 21, 2013
Assignee: Nant Holdings IP, LLC Inventor: Thomas Wittenschlaeger Backhaul fabric for wireless network
Patent number: 8493889
Abstract: A managed surface-space network fabric is presented. The surface-space network fabric can include a spaced-based network fabric and a surface-based network fabric integrated together to form a single fabric managed by a global fabric manager. The global fabric manager cooperates with other fabric managers local to each fabric to establish a communication topology among all the nodes of the fabric. Preferred topologies include paths from any port on a node to any other port on another node in the fabric. The surface-space fabric, and each individual fabric, can function as a distributed core fabric operating as a single, coherent device.
Type: Grant
Filed: April 23, 2012
Issued: July 23, 2013
Assignee: Nant Holdings IP, LLC Inventor: Thomas Wittenschlaeger
NON-OVERLAPPING SECURED TOPOLOGIES IN A DISTRIBUTED NETWORK FABRIC
Application number: 20130101291
Abstract: Networks comprising multiple non-overlapping communication topologies are presented. The networks can include a fabric of interconnected network nodes capable of providing multiple communication paths among edge devices. A topology manager constructs communication topologies according to restriction criteria based on required security levels (e.g., top secret, secret, unclassified, etc.). Established topologies do not have overlapping networking infrastructure to within the bounds of the restriction criteria as allowed by the security levels.
Type: Application
Filed: October 16, 2012
Issued: April 25, 2013
Assignee: NANT HOLDINGS IP, LLC Inventor: Thomas Wittenschlaeger DYNAMIC PACKET ROUTING
Application number: 20130094498
Abstract: Dynamic packet routing based on fabric awareness information is presented. Networking nodes in a networking fabric observe environmental properties across the fabric. When differences in environment properties between portions of the fabric are detected, differences in power consumption costs for example, the fabric generates corresponding routing tables. The networking nodes can then route traffic in a manner that is sensitive to the environment properties, power consumption or the cost of power for example.
Type: Application
Filed: September 25, 2012
Issued: April 18, 2013
Assignee: NANT HOLDINGS IP, LLC Inventor: Thomas Wittenschlaeger
Software application striping
Patent number: 8364744
Abstract: A distributed computing system comprising networking infrastructure and methods of executing an application on the distributed computing system is presented. Interconnected networking nodes offering available computing resources form a network fabric. The computing resources can be allocated from the networking nodes, including available processing cores or memory elements located on the networking nodes. A software application can be stored in a system memory comprising memory elements allocated from the nodes. The software application can be disaggregated into a plurality of executable portions that are striped across the allocated processing cores by assigning each core a portion to execute. When the cores are authenticated with respect to their portions, the cores are allowed to execute the portions by accessing the system memory over the fabric. While executing the software application, the networking nodes having the allocated cores concurrently forward packets through the fabric.
Type: Grant
Filed: September 9, 2009
Issued: January 29, 2013
Assignee: Nant Holdings IP, LLC Inventor: Thomas Wittenschlaeger
Distributed computing bus
Patent number: 8296465
Abstract: A distributed computing bus that provides both data transport and ambient computing power is provided. Contemplated buses comprise a network fabric of interconnected networking infrastructure nodes capable of being programmed before or after installation in the field. A fabric manager organizes the fabric into a bus topology communicatively coupling computing elements that exchange payload data using a bus protocol. Nodes within the bus topology operate on the payload data as the data passes through the node on route to its destination.
Type: Grant
Filed: March 7, 2011
Issued: October 23, 2012
Assignee: Nant Holdings, IP, LLC Inventor: Thomas Wittenschlaeger BACKHAUL FABRIC FOR WIRELESS NETWORK
Application number: 20120207016
Abstract: A managed surface-space network fabric is presented. The surface-space network fabric can include a spaced-based network fabric and a surface-based network fabric integrated together to form a single fabric managed by a global fabric manager. The global fabric manager cooperates with other fabric managers local to each fabric to establish a communication topology among all the nodes of the fabric. Preferred topologies include paths from any port on a node to any other port on another node in the fabric. The surface-space fabric, and each individual fabric, can function as a distributed core fabric operating as a single, coherent device.
Type: Application
Filed: April 23, 2012
Issued: August 16, 2012
Assignee: RAPTOR ACQUISITION, LLC
Inventor: Thomas Wittenschlaeger Distributed Network Interfaces for Application Cloaking and Spoofing
Application number: 20120166601
Abstract: Systems and methods associated with distributing an application's network interface over nodes of a networking fabric are presented. Nodes of the fabric can operate as interface modules, each taking on a role or responsibility for a portion of the application's network address including IP address, port assignments, or other portions of the network address. Interface modules of the networking nodes can then spoof or cloak the application to provide security against internal or external threats.
Type: Application
Filed: February 9, 2011
Issued: June 28, 2012
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger Surface-space managed network fabric
Patent number: 8189496
Abstract: A managed surface-space network fabric is presented. The surface-space network fabric can include a spaced-based network fabric and a surface-based network fabric integrated together to form a single fabric managed by a global fabric manager. The global fabric manager cooperates with other fabric managers local to each fabric to establish a communication topology among all the nodes of the fabric. Preferred topologies include paths from any port on a node to any other port on another node in the fabric. The surface-space fabric, and each individual fabric, can function as a distributed core fabric operating as a single, coherent device.
Type: Grant
Filed: September 1, 2009
Issued: May 29, 2012
Assignee: Raptor Acquisition, LLC
Inventor: Thomas Wittenschlaeger Vector-Based Anomaly Detection
Application number: 20120131674
Abstract: Methods of detecting anomalous behaviors associated with a fabric are presented. A network fabric can comprise many fungible networking nodes, preferably hybrid-fabric apparatus capable of routing general purpose packet data and executing distributed applications. A nominal behavior can be established for the fabric and represented by a baseline vector of behavior metrics. Anomaly detection criteria can be derived as a function of a variation from the baseline vector based on measured vectors of behavior metrics. Nodes in the fabric can provide a status for one or more anomaly criterion, which can be aggregated to determine if an anomalous behavior has occurred, is occurring, or is about to occur.
Type: Application
Filed: February 9, 2011
Issued: May 24, 2012
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger Distributed Computing Bus
Application number: 20110161527
Abstract: A distributed computing bus that provides both data transport and ambient computing power is provided. Contemplated buses comprise a network fabric of interconnected networking infrastructure nodes capable of being programmed before or after installation in the field. A fabric manager organizes the fabric into a bus topology communicatively coupling computing elements that exchange payload data using a bus protocol. Nodes within the bus topology operate on the payload data as the data passes through the node on route to its destination.
Type: Application
Filed: March 7, 2011
Issued: June 30, 2011
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger Distributed computing bus
Patent number: 7904602
Abstract: A distributed computing bus that provides both data transport and ambient computing power is provided. Contemplated buses comprise a network fabric of interconnected networking infrastructure nodes capable of being programmed before or after installation in the field. A fabric manager organizes the fabric into a bus topology communicatively coupling computing elements that exchange payload data using a bus protocol. Nodes within the bus topology operate on the payload data as the data passes through the node on route to its destination.
Type: Grant
Filed: May 16, 2008
Issued: March 8, 2011
Assignee: Raptor Networks Technology, Inc.
Inventor: Thomas Wittenschlaeger Hybrid Transport - Application Network Fabric Apparatus
Application number: 20100312913
Abstract: A hybrid routing-application network fabric apparatus is presented where a fabric apparatus has multiple apparatus components or resources that can be dedicated to one or more application topologies. The apparatus can receive a topology image definition file describing an application topology and the apparatus can dedicate its local components for use with the application topology. The apparatus can dedicate general purpose processing cores, dedicated routing cores, data channels, networking ports, memory or other local resources to the application topology. Contemplated application topologies include routing topologies, computation topologies, database topologies, storage topologies, or other types of application topologies. Furthermore, application topologies can be optimized by modeling or simulating the topologies on a network fabric.
Type: Application
Filed: August 3, 2010
Issued: December 9, 2010
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger Software Application Striping
Application number: 20090327446
Abstract: A distributed computing system comprising networking infrastructure and methods of executing an application on the distributed computing system is presented. Interconnected networking nodes offering available computing resources form a network fabric. The computing resources can be allocated from the networking nodes, including available processing cores or memory elements located on the networking nodes. A software application can be stored in a system memory comprising memory elements allocated from the nodes. The software application can be disaggregated into a plurality of executable portions that are striped across the allocated processing cores by assigning each core a portion to execute. When the cores are authenticated with respect to their portions, the cores are allowed to execute the portions by accessing the system memory over the fabric. While executing the software application, the networking nodes having the allocated cores concurrently forward packets through the fabric.
Type: Application
Filed: September 9, 2009
Issued: December 31, 2009
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger Surface-Space Managed Network Fabric
Application number: 20090316619
Abstract: A managed surface-space network fabric is presented. The surface-space network fabric can include a spaced-based network fabric and a surface-based network fabric integrated together to form a single fabric managed by a global fabric manager. The global fabric manager cooperates with other fabric managers local to each fabric to establish a communication topology among all the nodes of the fabric. Preferred topologies include paths from any port on a node to any other port on another node in the fabric. The surface-space fabric, and each individual fabric, can function as a distributed core fabric operating as a single, coherent device.
Type: Application
Filed: September 1, 2009
Issued: December 24, 2009
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger Software application striping
Patent number: 7603428
Abstract: A distributed computing system comprising networking infrastructure and methods of executing an application on the distributed computing system is presented. Interconnected networking nodes offering available computing resources form a network fabric. The computing resources can be allocated from the networking nodes, including available processing cores or memory elements located on the networking nodes. A software application can be stored in a system memory comprising memory elements allocated from the nodes. The software application can be disaggregated into a plurality of executable portions that are striped across the allocated processing cores by assigning each core a portion to execute. When the cores are authenticated with respect to their portions, the cores are allowed to execute the portions by accessing the system memory over the fabric. While executing the software application, the networking nodes having the allocated cores concurrently forward packets through the fabric.
Type: Grant
Filed: December 18, 2008
Issued: October 13, 2009
Assignee: Raptor Networks Technology, Inc.
Inventor: Thomas Wittenschlaeger Surface-space managed network fabric
Patent number: 7599314
Abstract: A managed surface-space network fabric is presented. The surface-space network fabric can include a spaced-based network fabric and a surface-based network fabric integrated together to form a single fabric managed by a global fabric manager. The global fabric manager cooperates with other fabric managers local to each fabric to establish a communication topology among all the nodes of the fabric. Preferred topologies include paths from any port on a node to any other port on another node in the fabric. The surface-space fabric, and each individual fabric, can function as a distributed core fabric operating as a single, coherent device.
Type: Grant
Filed: October 13, 2008
Issued: October 6, 2009
Assignee: Raptor Networks Technology, Inc.
Inventor: Thomas Wittenschlaeger
Software Application Striping
Application number: 20090198792
Abstract: A distributed computing system comprising networking infrastructure and methods of executing an application on the distributed computing system is presented. Interconnected networking nodes offering available computing resources form a network fabric. The computing resources can be allocated from the networking nodes, including available processing cores or memory elements located on the networking nodes. A software application can be stored in a system memory comprising memory elements allocated from the nodes. The software application can be disaggregated into a plurality of executable portions that are striped across the allocated processing cores by assigning each core a portion to execute. When the cores are authenticated with respect to their portions, the cores are allowed to execute the portions by accessing the system memory over the fabric. While executing the software application, the networking nodes having the allocated cores concurrently forward packets through the fabric.
Type: Application
Filed: December 18, 2008
Issued: August 6, 2009
Assignee: Raptor Networks Technology, Inc.
Inventor: Thomas Wittenschlaeger Distributed Computing Bus
Application number: 20090198836
Abstract: A distributed computing bus that provides both data transport and ambient computing power is provided. Contemplated buses comprise a network fabric of interconnected networking infrastructure nodes capable of being programmed before or after installation in the field. A fabric manager organizes the fabric into a bus topology communicatively coupling computing elements that exchange payload data using a bus protocol. Nodes within the bus topology operate on the payload data as the data passes through the node on route to its destination.
Type: Application
Filed: May 16, 2008
Issued: August 6, 2009
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger « prev 1 2
Surface-Space Managed Network Fabric
Application number: 20090154391
Abstract: A managed surface-space network fabric is presented. The surface-space network fabric can include a spaced-based network fabric and a surface-based network fabric integrated together to form a single fabric managed by a global fabric manager. The global fabric manager cooperates with other fabric managers local to each fabric to establish a communication topology among all the nodes of the fabric. Preferred topologies include paths from any port on a node to any other port on another node in the fabric. The surface-space fabric, and each individual fabric, can function as a distributed core fabric operating as a single, coherent device.
Type: Application
Filed: October 13, 2008
Issued: June 18, 2009
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger
DISAGGREGATED NETWORK MANAGEMENT
Application number: 20090157860
Abstract: Systems and methods for disaggregated management of a network fabric are presented. Network elements composing the network fabric can operate as a fabric manager with respect to one or more management functions while also continuing to operate as a communication conduit among hosts using the fabric. The roles or responsibilities of a fabric manager can migrate from one network element to another to preserve management coherency as well as to secure management of the network. Additionally, fabric managers communicate with the network fabric through one or more management channels.
Type: Application
Filed: May 13, 2008
Issued: June 18, 2009
Assignee: RAPTOR NETWORKS TECHNOLOGY, INC.
Inventor: Thomas Wittenschlaeger Disaggregated network management
Patent number: 7548545
Abstract: Systems and methods for disaggregated management of a network fabric are presented. Network elements composing the network fabric can operate as a fabric manager with respect to one or more management functions while also continuing to operate as a communication conduit among hosts using the fabric. The roles or responsibilities of a fabric manager can migrate from one network element to another to preserve management coherency as well as to secure management of the network. Additionally, fabric managers communicate with the network fabric through one or more management channels.
Type: Grant
Filed: May 13, 2008
Issued: June 16, 2009
Assignee: Raptor Networks Technology, Inc.
Inventor: Thomas Wittenschlaeger
KEYO TIMELINE
02/14/11 | Jerome Snyder leaves KeyOn with 2,096,365 shares of common stock. |
03/17/10 | California Capital Limited Partnership, an joint investment venture between PSS and Steven H. Hassan / Themba, LLC, purchases a 20M share stake in KEYO |
04/08/11 | California Capital Limited Partnership is dissolved and PSS forms California Capital Equity, LLC (CCE), acquiring 26,615,068 shares as sole owner. |
06/xx/11 | PSS buys the national Lambda Rail: http://www.flinn.org/news/1015 |
06/22/11 | CCE / PSS acquires the full 30,081,734 shares of KEYO becoming 79.1% beneficial owner of the company. |
07/05/11 | CCE purchases Raptor Networks. PSS meets TW? |
08/17/11 | PSS appoints Charles Kim and Christian Zapf, his Investment Attorneys, to the KEYO BOD. |
12/05/11 | PSS and TW secure the IP from Raptor Networks and sell the shell to Lantis Laser. |
12/16/11 | TW takes over KEYO and closes the company, leaving the KEYO shell as it is today. |
03/03/14 | KEYO trades 10,222,719 shares. The reason for this volume is unknown. |
03/27/14 | Keyon Communications, Inc. is reinstated with the Nevada SOS: https://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=z3AcJdFE8L9UKmaKreVn1A%253d%253d&CorpName=KEYON+COMMUNICATIONS%2c+INC. |
05/21/14 | Keyon Communications, Inc. is dissolved with the Nevada SOS: https://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=z3AcJdFE8L9UKmaKreVn1A%253d%253d&CorpName=KEYON+COMMUNICATIONS%2c+INC. |
Background on Dr. Patrick Soon-Shiong, M.D., MSc, FRCS(C), FACS.
BIOGRAPHY:
Wikipedia
Curriculum Vitae
Chinese American Heroes
HIS VISION:
05/xx/98 | Can Dr. Soon-Shiong Perform Miracles? - A New Trial for 24 Islet Cell Transplant Recipients |
10/06/03 | Vindication - VivoRX to APP [Forbes] |
xx/xx/05 | American Pharmaceutical Partners, Inc. History |
10/29/09 | Billionaire offers $100-million guaranty to reopen King hospital |
11/10/11 | Billionaire Patrick Soon-Shiong Wants To Remake The U.S. Health Care System |
10/03/12 | "This is something the federal government should have done, but we waited and waited for them," Soon-Shiong told Reuters in an interview. |
01/14/14 | #knowyourself- A collection of news and information in science, technology, and health. - Spotlight: Patrick Soon-Shiong |
09/xx/14 | Bipartisan Policy Center - Innovative Strategies from America's Business Leaders - A report from the CEO Council on Health and Innovation (A large .pdf file. Well worth the read, particularly ppgs 89 - 95 and pg 103: Overview and Appendix A) |
NOTABLE NEWS:
10/27/11 | PSS tries to save the CCMS. A good look into what he faces with governmental beauracracy. Part 1 : Part 2 : Part 3 : Part 4 |
CORPORATE LINKS: | OTHER LINKS: |
NantWorks | Nant Holdings IP, LLC - Intellectual Property held by NantWorks - Patents and Trademarks |
NantStudio | PSS's IP - Dr. Patrick Soon-Shiong's Patent Portfolio |
NantCloud - Teaser! | California Capital Equity, LLC - IP - SEC Docs - PSS's controling interest in KeyOn Communications Holdings, Inc, - OTCPK: KEYO |
NantMobile | Nant Capital, LLC - IP |
NantHealth | Expression Pathology Inc - IP |
NantPharma | California Capital Z, LLC - PSS's investment in Jakks Pacific - NASDAQ: JAKK |
NantCell - No URL | Nant Capital, LLC |
NantBioscience - No URL | Nant Media |
NantTronics - No URL | Nant TV |
NantOmics - No URL | Nant Vision |
NantShield - No URL | Tom Wittenschlaeger's IP |
NantSound | |
SKULL AND CROSSBONES FOR KEYO.
http://www.otcmarkets.com/stock/KEYO/quote
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |